GCM
ABMD

Gunderson Capital Management’s Abiomed Inc ABMD Stock Holding History

Gunderson Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,574
Closed -$863K – 61
2020
Q2 		$863K Buy
+3,574
New +$718K 0.69% 38
2019
Q2 		– Sell
-1,962
Closed -$560K – 72
2019
Q1 		$560K Buy
+1,962
New +$652K 0.49% 41

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gunderson Capital Management's ABMD Position: Q3 2020 in Review

Gunderson Capital Management sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 3,574 shares — an estimated $863K sold.

Gunderson Capital Management first reported a position in ABMD in Q1 2019 and held it in 2 quarters. The position peaked at $863K in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Gunderson Capital Management reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 3,574 Abiomed Inc shares in Q3 2020, an estimated $863K.
  • Gunderson Capital Management first reported a position in Abiomed Inc in Q1 2019 and held it in 2 quarters.
  • Gunderson Capital Management's Abiomed Inc position peaked at $863K in Q2 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Gunderson Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.